| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 04/08/2004 | WO2004004634A3 Infertility treatment with exemestane |
| 04/07/2004 | EP1404701A1 Method for preparing oestrogen derivatives |
| 04/07/2004 | EP1404700A2 Process for the production of 6,7-dihydroxy steroid compounds by allylic oxidation of steroid-5-ene compounds to steroid-5-ene-7-one compounds followed by hydroboration and oxidation and intermediates of this process |
| 04/07/2004 | CN1487950A Androgenic 7-substituted 11-halogen steroids |
| 04/06/2004 | US6717002 Reacting a 19- norsteroid derivative with an alcohol represented by roh and iodine in the absence of a rare earth compound catalyst |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063172 Therapy for hormone sensitive diseases; contraceptives |
| 03/31/2004 | EP0977578B1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 03/25/2004 | WO2002101014A3 A process for making estra-4,9(10)-diene steroids |
| 03/25/2004 | US20040059140 14(15)-unsaturated 15- and/or 16-substituted androgens with mixed androgen-progrestational profile |
| 03/24/2004 | EP1399221A1 Compositions comprising oestrone-3-o-sulphamate and trail (tnf-related apoptosis inducing ligand) |
| 03/18/2004 | WO2003102012A9 New etonogestrel esters |
| 03/18/2004 | WO2002076435A3 Lipid profile modulation with steroids |
| 03/18/2004 | US20040053905 Method for the production of 4-(17$g(a) substituted 3-oxoestra-4,9-dien-11$g(b)-yl) benzaldehyd-(1e or 1z)-oximes |
| 03/17/2004 | CN1482135A Estrogen compound of bone tendency, preparing method and application thereof |
| 03/17/2004 | CN1482134A Estrogen compound of bone tendency, preparing method and application thereof |
| 03/17/2004 | CN1142175C Sulfurization for oestrogen mixture |
| 03/16/2004 | US6706701 6, 7-oxygenated steroids and uses related thereto |
| 03/11/2004 | WO2003079961A3 Method for producing 7$g(a)-methyl steroids |
| 03/10/2004 | CN1481388A 14(15)-unsturated 15-and/or 16-substituted androgens with mixed androgen-progestational profile |
| 03/04/2004 | US20040044234 Binding to estrogen receptors |
| 03/04/2004 | US20040043976 16Alpha-methyl or ethyl substituted estrogens |
| 03/04/2004 | US20040043973 Pharmaceutical compositions and treatment methods |
| 03/04/2004 | US20040043972 Autoimmune disease; antidiabetic agents |
| 03/03/2004 | EP1392713A2 Liver x receptor agonists |
| 03/03/2004 | EP1392399A1 Use and compositions of antiprogestins for treatment of prostate diseases |
| 02/26/2004 | WO2004016640A2 5 ANDROSTEN-3β-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION |
| 02/26/2004 | WO2003101374A3 Use of new etonogestrel esters |
| 02/26/2004 | WO2003026568A3 Androstanes as androgen receptor modulators |
| 02/26/2004 | CA2495412A1 5 androsten-3.beta.-ol steroid intermediates and processes for their preparation |
| 02/24/2004 | US6696580 Steroids with a cyclohexene moiety are oxidized to the corresponding alpha, beta-unsaturated ketone that is converted to the corresponding vicinal diol using a hydroborating reagent followed by oxidative workup |
| 02/24/2004 | CA2309796C Carbonate derivatives of retinol, process for their preparation and uses |
| 02/19/2004 | WO2004014935A1 Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
| 02/19/2004 | WO2004014934A2 Process and new intermediates for the preparation of steroids with a progestogen activity |
| 02/19/2004 | WO2003045398A8 Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 02/19/2004 | WO2002032429A3 Use of inhibitors of progesterone receptor for treating cancer |
| 02/19/2004 | US20040034215 A 7beta-hydroxy steroid is produced by fermentation, hydrolysis; an intermediate for producing eplerenone |
| 02/19/2004 | US20040034029 Composition and method for altering levels of or sensitivity to adenosine with a dehydroepiandrosterone |
| 02/19/2004 | US20040034003 7-Hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof |
| 02/19/2004 | US20040033999 Testosterone derivative |
| 02/19/2004 | DE10236405A1 New 4-(3-oxo-estra-4,9-dien-11 beta-yl)-benzaldehyde oximes, are progesterone receptor modulators useful in female contraception, hormone replacement therapy and treatment of gynecological disorders |
| 02/18/2004 | EP1163256B1 Hemihydrate of 16.alpha.-bromoepiandrosterone |
| 02/18/2004 | CN1138526C Intravaginal drug delivery devices for administration of 17 beta-oestradiol precursors |
| 02/17/2004 | US6693207 5,7,9-estratriene derivative having atleast one sulfate salt at 3 or 17 position of the ring; anti-osteoporosis compound |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | DE10233723A1 Preparation of 7 alpha-substituted 11 alpha-hydroxy-steroids, useful as precursors for new androgenic 7 alpha,17 alpha-substituted 11 beta-halo-steroids, by microbiological conversion of 7 alpha-substituted steroids |
| 02/11/2004 | EP1387851A1 Process for the synthesis of oxandrolone |
| 02/11/2004 | CN1474829A Method for production of 4-(17 alpha-substituted-3-oxoestra-4,9-dien-11-yl) benzaldehyd-(1E or 12)-oximes |
| 02/11/2004 | CN1137691C heterogeneous contraception preparation based on natural estrogen |
| 02/05/2004 | WO2004011663A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 02/05/2004 | US20040024231 Such as 17-beta-hydroxy-17-alpha-trifluoromethyl-7-alpha-methyl-androst-4-en-3-one; for hormone replacement therapy |
| 02/05/2004 | US20040024202 C-17 spirolactonization and 6,7 oxidation of steroids |
| 02/05/2004 | US20040024044 In chemoprevention of estrogen dependent cancer in mammals, including humans |
| 02/05/2004 | US20040023936 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 02/04/2004 | EP1385868A2 Steroidal derivatives |
| 02/04/2004 | CN1473047A Method for treating hypogonadism |
| 01/29/2004 | US20040019028 Administering to a patient with mild cognitive impairment, a specific glucocorticoid receptor antagonist such as mifepristone to improve performance on a paragraph recall test |
| 01/29/2004 | US20040019026 Compounds useful for treating hypertriglyceridemia |
| 01/29/2004 | US20040019023 Administering 9,10-secopregna-5,7,10(19),16- tetraene derivative to a patient for treating skin diseases such as psoriasis |
| 01/28/2004 | EP1214077B1 Local delivery of 17-beta estradiol for improving vascular endothelium function after vascular injury |
| 01/27/2004 | CA2115015C Process for the preparation of 6alpha,9alpha-difluorinated steroids and novel intermediates obtained thereby |
| 01/21/2004 | EP1382340A1 Therapeutic uses of dehydroepiandrosterone for treating diminished libido and osteoporosis |
| 01/15/2004 | WO2004004634A2 Infertility treatment with exemestane |
| 01/15/2004 | US20040010138 Process for the production of 7alpha-methyl steroids |
| 01/15/2004 | DE10226326A1 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene 9-alpha-substiuierte estratrienes as selective estrogens effective |
| 01/15/2004 | CA2491372A1 Infertility treatment with exemestane |
| 01/14/2004 | EP1380300A1 Oestrogen and fatty acid monoester as a hypolipidaemic and antidiabetic agent |
| 01/14/2004 | EP1379542A2 Treatment of tumours |
| 01/14/2004 | EP1379327A1 Method for the rapid thermal activation of a chemical reaction in a supercritical fluid solution |
| 01/14/2004 | EP1379253A1 Methods of making and pharmaceutical formulations comprising 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 01/13/2004 | US6677329 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 01/08/2004 | US20040006051 Estrogen-linked platinum (II) complexes as anticancer agents |
| 01/08/2004 | US20040006007 Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides |
| 01/07/2004 | CN1466592A 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds |
| 01/07/2004 | CN1466467A Pharmaceutical composition and method for treating hypogonadism |
| 01/02/2004 | EP1372664A1 Use of certain steroids for treatment of blood cell deficiencies |
| 01/02/2004 | EP1203011B1 Orally active androgens |
| 01/01/2004 | US20040002482 Androgen pharmaceutical composition and method for treating depression |
| 01/01/2004 | US20040001837 Betulinol derivatives |
| 12/30/2003 | US6670493 Methods and compositions for treating diseases due to androgen deficiency with glucocorticoid receptor antagonist compounds and new compounds |
| 12/30/2003 | US6670352 Androgenic steroid compounds and a method of making and using the same |
| 12/30/2003 | US6670349 Asthma |
| 12/25/2003 | US20030236408 Estrogenic compounds as anti-mitotic agents |
| 12/24/2003 | DE10213371C1 Verfahren zur Herstellung von 7alpha-Methylsteroiden Process for the preparation of 7alpha-methyl steroids |
| 12/23/2003 | US6667299 16-alpha-bromo-3-beta-hydroxy-5-alpha-androstan-17-one hemihydrate; 16-alpha-bromoepiandrosterone; steroid; immune modulator |
| 12/23/2003 | CA2147172C Transdermal therapeutic system for the release of 17-.beta.-estradiol and process for its production |
| 12/18/2003 | WO2003104254A2 Novel derivatives of androstane and androstene with ascorbic a cid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 12/18/2003 | WO2003104253A2 9-alpha-substituted estratrienes as selectively active estrogen |
| 12/18/2003 | WO2002090375A3 Liver x receptor agonists |
| 12/18/2003 | US20030232981 Contacting a Delta 3,5-3-enol ether of formula (alkyl enol ether) with a hydride abstractor and an alcohol |
| 12/18/2003 | US20030232797 Useful as immunomodulating and antiinflammatory compounds and in treatment of cardiovascular disease and cancer |
| 12/18/2003 | CA2488618A1 Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 12/17/2003 | EP1370268A2 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 12/11/2003 | WO2003102012A2 New etonogestrel esters |
| 12/11/2003 | WO2003101374A2 Use of new etonogestrel esters |
| 12/11/2003 | US20030229061 Novel 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
| 12/11/2003 | US20030229060 Steroidal quinols and their use for antioxidant therapy |
| 12/11/2003 | US20030228355 Precipitation of lipid; fineness particle size |
| 12/11/2003 | CA2487293A1 Use of new etonogestrel esters |
| 12/10/2003 | EP1368037A2 Estrogen replacement therapy |